273 related articles for article (PubMed ID: 9808710)
1. Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA.
Chiang N; Takano T; Clish CB; Petasis NA; Tai HH; Serhan CN
J Pharmacol Exp Ther; 1998 Nov; 287(2):779-90. PubMed ID: 9808710
[TBL] [Abstract][Full Text] [Related]
2. Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation.
Clària J; Lee MH; Serhan CN
Mol Med; 1996 Sep; 2(5):583-96. PubMed ID: 8898374
[TBL] [Abstract][Full Text] [Related]
3. Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart.
Birnbaum Y; Ye Y; Lin Y; Freeberg SY; Huang MH; Perez-Polo JR; Uretsky BF
Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):89-98. PubMed ID: 17259075
[TBL] [Abstract][Full Text] [Related]
4. Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization.
Romano M; Maddox JF; Serhan CN
J Immunol; 1996 Sep; 157(5):2149-54. PubMed ID: 8757340
[TBL] [Abstract][Full Text] [Related]
5. Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4.
Planagumà A; Titos E; López-Parra M; Gaya J; Pueyo G; Arroyo V; Clària J
FASEB J; 2002 Dec; 16(14):1937-9. PubMed ID: 12368230
[TBL] [Abstract][Full Text] [Related]
6. Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction.
Filep JG; Khreiss T; József L
Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):257-62. PubMed ID: 15979865
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion.
Chiang N; Gronert K; Clish CB; O'Brien JA; Freeman MW; Serhan CN
J Clin Invest; 1999 Aug; 104(3):309-16. PubMed ID: 10430612
[TBL] [Abstract][Full Text] [Related]
8. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
Serhan CN
Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
[TBL] [Abstract][Full Text] [Related]
9. Anti-microinflammatory lipid signals generated from dietary N-3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and N-3 PUFA therapeutic actions.
Serhan CN; Clish CB; Brannon J; Colgan SP; Gronert K; Chiang N
J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):643-54. PubMed ID: 11192938
[TBL] [Abstract][Full Text] [Related]
10. Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis.
Hachicha M; Pouliot M; Petasis NA; Serhan CN
J Exp Med; 1999 Jun; 189(12):1923-30. PubMed ID: 10377187
[TBL] [Abstract][Full Text] [Related]
11. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors.
Takano T; Fiore S; Maddox JF; Brady HR; Petasis NA; Serhan CN
J Exp Med; 1997 May; 185(9):1693-704. PubMed ID: 9151906
[TBL] [Abstract][Full Text] [Related]
12. Lipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritis.
O'Meara YM; Brady HR
Kidney Int Suppl; 1997 Mar; 58():S56-61. PubMed ID: 9067945
[TBL] [Abstract][Full Text] [Related]
13. Characterization of lipoxins by combined gas chromatography and electron-capture negative ion chemical ionization mass spectrometry: formation of lipoxin A4 by stimulated human whole blood.
Brezinski DA; Serhan CN
Biol Mass Spectrom; 1991 Feb; 20(2):45-52. PubMed ID: 1883860
[TBL] [Abstract][Full Text] [Related]
14. Lipoxin A4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin.
Menezes-de-Lima O; Kassuya CA; Nascimento AF; Henriques Md; Calixto JB
Prostaglandins Other Lipid Mediat; 2006 Sep; 80(3-4):123-35. PubMed ID: 16939877
[TBL] [Abstract][Full Text] [Related]
15. Lipoxin A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor-alpha-initiated neutrophil responses and trafficking: novel regulators of a cytokine-chemokine axis relevant to periodontal diseases.
Pouliot M; Serhan CN
J Periodontal Res; 1999 Oct; 34(7):370-3. PubMed ID: 10685363
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.
Takano T; Clish CB; Gronert K; Petasis N; Serhan CN
J Clin Invest; 1998 Feb; 101(4):819-26. PubMed ID: 9466977
[TBL] [Abstract][Full Text] [Related]
17. Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A(4).
Titos E; Chiang N; Serhan CN; Romano M; Gaya J; Pueyo G; Clària J
Am J Physiol; 1999 Nov; 277(5):C870-7. PubMed ID: 10564079
[TBL] [Abstract][Full Text] [Related]
18. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils.
Bae YS; Park JC; He R; Ye RD; Kwak JY; Suh PG; Ho Ryu S
Mol Pharmacol; 2003 Sep; 64(3):721-30. PubMed ID: 12920210
[TBL] [Abstract][Full Text] [Related]
19. Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils.
Qiu FH; Devchand PR; Wada K; Serhan CN
FASEB J; 2001 Dec; 15(14):2736-8. PubMed ID: 11687510
[TBL] [Abstract][Full Text] [Related]
20. Second-generation beta-oxidation resistant 3-oxa-lipoxin A4 analogs.
Guilford WJ; Parkinson JF
Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):245-50. PubMed ID: 15985364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
